Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Dr Reddy's Labs announces generic version of Straterra in US market

31 October, 2018 8:22 AM
87 0
Dr Reddy's Labs announces generic version of Straterra in US market

Dr Reddy's Laboratories on Wednesday announced the launch of Atomoxetine capsules used to treat attention-deficit hyperactivity disorder (ADHD) in the US market.

The Hyderabad-based company has received the approval from the US Food and Drug Administration (USFDA) to market its product which is a generic equivalent of Eli Lilly and Company's Straterra, Dr Reddy's Laboratories said in a statement.

As per the IMS Health sales data, the Strattera brand had the US sales of around USD 304 million for the most recent 12 months ending in August 2018.

Source: moneycontrol.com

Share in social networks:

Comments - 0